

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.05571112 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.05571112 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.64864578 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64864578 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.24446739 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66877913 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.58518425 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.58518425 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.58518425 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.46515573 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.36760995 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.24093574 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06979819 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.04676867 |
| 15 | urea cycle (GO:0000050) | 4.96045148 |
| 16 | urea metabolic process (GO:0019627) | 4.96045148 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 4.82328558 |
| 18 | bile acid metabolic process (GO:0008206) | 4.67813485 |
| 19 | cysteine metabolic process (GO:0006534) | 4.65593627 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.61261886 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.57700020 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 4.52574984 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.49762585 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 4.49681323 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.46903701 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.42916530 |
| 27 | protein carboxylation (GO:0018214) | 4.42916530 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.40417785 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.39333006 |
| 30 | reverse cholesterol transport (GO:0043691) | 4.39312363 |
| 31 | phospholipid efflux (GO:0033700) | 4.30049489 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.29646823 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25986335 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.25986335 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.25986335 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25833959 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.24360612 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.24163294 |
| 39 | negative regulation of sterol transport (GO:0032372) | 4.16247687 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.16247687 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.14861959 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.14861959 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.13789040 |
| 44 | glutamate metabolic process (GO:0006536) | 4.12641830 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.10014811 |
| 46 | mannose metabolic process (GO:0006013) | 4.08580421 |
| 47 | regulation of complement activation (GO:0030449) | 4.06390612 |
| 48 | drug catabolic process (GO:0042737) | 4.06298670 |
| 49 | coenzyme catabolic process (GO:0009109) | 4.04812189 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.02199613 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.00317104 |
| 52 | epoxygenase P450 pathway (GO:0019373) | 3.98243869 |
| 53 | cholesterol efflux (GO:0033344) | 3.96954916 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.96662684 |
| 55 | amine catabolic process (GO:0009310) | 3.93455893 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 3.93455893 |
| 57 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.93171048 |
| 58 | bile acid and bile salt transport (GO:0015721) | 3.92270206 |
| 59 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.86509225 |
| 60 | cellular glucuronidation (GO:0052695) | 3.85062492 |
| 61 | synaptic vesicle exocytosis (GO:0016079) | 3.84608412 |
| 62 | lysine catabolic process (GO:0006554) | 3.84230735 |
| 63 | lysine metabolic process (GO:0006553) | 3.84230735 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.83709785 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 3.78140213 |
| 66 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.75127354 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73511680 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 3.72556101 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 3.71928551 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 3.68506181 |
| 71 | glutamate secretion (GO:0014047) | 3.62168781 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 3.61754880 |
| 73 | NADH metabolic process (GO:0006734) | 3.60103780 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 3.56967683 |
| 75 | ketone body metabolic process (GO:1902224) | 3.56282353 |
| 76 | negative regulation of lipase activity (GO:0060192) | 3.54980957 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.54349617 |
| 78 | ethanol oxidation (GO:0006069) | 3.53260707 |
| 79 | short-chain fatty acid metabolic process (GO:0046459) | 3.52022638 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.50930211 |
| 81 | uronic acid metabolic process (GO:0006063) | 3.48814826 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.48814826 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.45155928 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.44427513 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.44427513 |
| 86 | aldehyde catabolic process (GO:0046185) | 3.44274931 |
| 87 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42992336 |
| 88 | drug transmembrane transport (GO:0006855) | 3.42559012 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.39452227 |
| 90 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.39082835 |
| 91 | regulation of cholesterol homeostasis (GO:2000188) | 3.37470905 |
| 92 | arginine metabolic process (GO:0006525) | 3.37018069 |
| 93 | serine family amino acid metabolic process (GO:0009069) | 3.36587892 |
| 94 | cytolysis (GO:0019835) | 3.34106008 |
| 95 | cofactor catabolic process (GO:0051187) | 3.33192002 |
| 96 | glutathione biosynthetic process (GO:0006750) | 3.32828633 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.30680163 |
| 98 | regulation of cholesterol metabolic process (GO:0090181) | 3.29121501 |
| 99 | * carboxylic acid catabolic process (GO:0046395) | 3.27435119 |
| 100 | * organic acid catabolic process (GO:0016054) | 3.27435119 |
| 101 | fibrinolysis (GO:0042730) | 3.25798754 |
| 102 | glycine metabolic process (GO:0006544) | 3.25374221 |
| 103 | complement activation, classical pathway (GO:0006958) | 3.25260302 |
| 104 | sterol homeostasis (GO:0055092) | 3.25245348 |
| 105 | very long-chain fatty acid metabolic process (GO:0000038) | 3.24139719 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.23177346 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.22338924 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.21162761 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.20558664 |
| 110 | indole-containing compound metabolic process (GO:0042430) | 3.20035669 |
| 111 | neurotransmitter secretion (GO:0007269) | 3.17249132 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.17232586 |
| 113 | regulation of ARF protein signal transduction (GO:0032012) | 3.14552670 |
| 114 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.07234731 |
| 115 | ethanol metabolic process (GO:0006067) | 3.05986562 |
| 116 | synaptic vesicle maturation (GO:0016188) | 3.03752147 |
| 117 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.01706448 |
| 118 | neurotransmitter catabolic process (GO:0042135) | 3.00516323 |
| 119 | fructose metabolic process (GO:0006000) | 2.96680412 |
| 120 | amyloid precursor protein catabolic process (GO:0042987) | 2.92272738 |
| 121 | GDP-mannose metabolic process (GO:0019673) | 2.90785320 |
| 122 | peptide biosynthetic process (GO:0043043) | 2.88142834 |
| 123 | sodium ion export (GO:0071436) | 2.84169853 |
| 124 | drug metabolic process (GO:0017144) | 2.83655520 |
| 125 | regulation of synapse maturation (GO:0090128) | 2.79663342 |
| 126 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.78897981 |
| 127 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.77898349 |
| 128 | amyloid precursor protein metabolic process (GO:0042982) | 2.74402814 |
| 129 | angiotensin maturation (GO:0002003) | 2.74262086 |
| 130 | alkaloid metabolic process (GO:0009820) | 2.68678535 |
| 131 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.66853136 |
| 132 | biotin metabolic process (GO:0006768) | 2.65714880 |
| 133 | regulation of neurotransmitter levels (GO:0001505) | 2.63997813 |
| 134 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.63865238 |
| 135 | gamma-aminobutyric acid transport (GO:0015812) | 2.63497462 |
| 136 | negative regulation of cell size (GO:0045792) | 2.61162988 |
| 137 | neurotransmitter biosynthetic process (GO:0042136) | 2.60565552 |
| 138 | cerebellar granule cell differentiation (GO:0021707) | 2.59490909 |
| 139 | proline metabolic process (GO:0006560) | 2.59262401 |
| 140 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.58696256 |
| 141 | myelin maintenance (GO:0043217) | 2.55528108 |
| 142 | cell-cell junction maintenance (GO:0045217) | 2.51023584 |
| 143 | creatine metabolic process (GO:0006600) | 2.50900431 |
| 144 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.46054455 |
| 145 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.44792050 |
| 146 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.43104588 |
| 147 | diacylglycerol metabolic process (GO:0046339) | 2.43090999 |
| 148 | sodium ion homeostasis (GO:0055078) | 2.40970281 |
| 149 | cellular potassium ion homeostasis (GO:0030007) | 2.39116854 |
| 150 | phenylpropanoid metabolic process (GO:0009698) | 2.37884219 |
| 151 | quaternary ammonium group transport (GO:0015697) | 2.36005892 |
| 152 | phospholipid scrambling (GO:0017121) | 2.33852785 |
| 153 | regulation of ARF GTPase activity (GO:0032312) | 2.33061042 |
| 154 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33046298 |
| 155 | multicellular organismal water homeostasis (GO:0050891) | 2.32699075 |
| 156 | neurotransmitter transport (GO:0006836) | 2.32062209 |
| 157 | neuronal ion channel clustering (GO:0045161) | 2.31037362 |
| 158 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.29949501 |
| 159 | dendritic spine organization (GO:0097061) | 2.28525879 |
| 160 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.26680311 |
| 161 | * monocarboxylic acid catabolic process (GO:0072329) | 2.24707524 |
| 162 | * fatty acid catabolic process (GO:0009062) | 2.24280426 |
| 163 | fatty acid beta-oxidation (GO:0006635) | 2.23094339 |
| 164 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.21877522 |
| 165 | amide biosynthetic process (GO:0043604) | 2.20611394 |
| 166 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.20072890 |
| 167 | sperm capacitation (GO:0048240) | 2.19165433 |
| 168 | actin filament polymerization (GO:0030041) | 2.18252844 |
| 169 | carnitine transport (GO:0015879) | 2.16750038 |
| 170 | amino-acid betaine transport (GO:0015838) | 2.16750038 |
| 171 | actin filament capping (GO:0051693) | 2.15551759 |
| 172 | omega-hydroxylase P450 pathway (GO:0097267) | 2.14907306 |
| 173 | cell junction maintenance (GO:0034331) | 2.13995811 |
| 174 | axon ensheathment in central nervous system (GO:0032291) | 2.13952350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.27267423 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.04091717 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.03465461 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.96057412 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.80155716 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.16481626 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.24220742 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.18796689 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.99240753 |
| 10 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.96583907 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.54032441 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.41836684 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.35914450 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31518214 |
| 15 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.20056796 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13744323 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.00874915 |
| 18 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.99572566 |
| 19 | * P68_20966046_ChIP-Seq_HELA_Human | 1.97234370 |
| 20 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.93985649 |
| 21 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.85061436 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80017524 |
| 23 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.79906865 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.74110774 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71913610 |
| 26 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.71210345 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67592802 |
| 28 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65623126 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64778145 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63917583 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.62719013 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61007502 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59476398 |
| 34 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.58254329 |
| 35 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57414861 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.56508461 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55638366 |
| 38 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.54200953 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47739303 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44782679 |
| 41 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44657860 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44308993 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43976463 |
| 44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40016161 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39881486 |
| 46 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39295511 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39262858 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36881604 |
| 49 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.36683824 |
| 50 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.36481757 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32135419 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31559280 |
| 53 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.28788996 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28076443 |
| 55 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.25201541 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24172710 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23311117 |
| 58 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.23260742 |
| 59 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.23002137 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22526381 |
| 61 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22210365 |
| 62 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21955063 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21750674 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20903941 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20790175 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19888157 |
| 67 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19637688 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18086367 |
| 69 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.17912121 |
| 70 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17318025 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17145497 |
| 72 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15692805 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13775603 |
| 74 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.13762187 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11884986 |
| 76 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.11587323 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10626250 |
| 78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10307293 |
| 79 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09826883 |
| 80 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09637202 |
| 81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08927265 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08581111 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05088089 |
| 84 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04317469 |
| 85 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04304397 |
| 86 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03791406 |
| 87 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.03150438 |
| 88 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02785257 |
| 89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02535300 |
| 90 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01137499 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00731067 |
| 92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99562560 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99153375 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98133332 |
| 95 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97296062 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96901615 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96470076 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95701374 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94301777 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93963205 |
| 101 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93740059 |
| 102 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93248578 |
| 103 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92998411 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92813017 |
| 105 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92639740 |
| 106 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92016760 |
| 107 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91524767 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91263084 |
| 109 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89503739 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88830951 |
| 111 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.88782442 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88176108 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88126677 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87608711 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87084522 |
| 116 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86844269 |
| 117 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86844269 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86694427 |
| 119 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.85346500 |
| 120 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85028710 |
| 121 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84182966 |
| 122 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82151985 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80062181 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79170208 |
| 125 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.78334767 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77964085 |
| 127 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77713975 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76721597 |
| 129 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76309736 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75907055 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75907055 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75869328 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75587803 |
| 134 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.75225751 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75117441 |
| 136 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74581414 |
| 137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74531332 |
| 138 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.72877061 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72408076 |
| 140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.72198880 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71537627 |
| 142 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71377457 |
| 143 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71027359 |
| 144 | KDM2B_26808549_Chip-Seq_REH_Human | 0.69888229 |
| 145 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.68736640 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.67141273 |
| 147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67078275 |
| 148 | STAT3_23295773_ChIP-Seq_U87_Human | 0.66932609 |
| 149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.66837534 |
| 150 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.65274149 |
| 151 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65243298 |
| 152 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.65102868 |
| 153 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.64584691 |
| 154 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63357973 |
| 155 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63357615 |
| 156 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63325252 |
| 157 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62254582 |
| 158 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.62012330 |
| 159 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61980075 |
| 160 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.61777615 |
| 161 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.61617857 |
| 162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61317324 |
| 163 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61010438 |
| 164 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.60128455 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.59152940 |
| 166 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.58625099 |
| 167 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58416053 |
| 168 | VDR_22108803_ChIP-Seq_LS180_Human | 0.58367253 |
| 169 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.58191967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.45069230 |
| 2 | MP0005360_urolithiasis | 7.06193404 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.85501782 |
| 4 | MP0005365_abnormal_bile_salt | 5.53885725 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.84724871 |
| 6 | MP0003252_abnormal_bile_duct | 3.58288051 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.24431080 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.19043727 |
| 9 | MP0009840_abnormal_foam_cell | 2.79292719 |
| 10 | MP0003195_calcinosis | 2.69249342 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.65968190 |
| 12 | MP0005332_abnormal_amino_acid | 2.50494032 |
| 13 | MP0005083_abnormal_biliary_tract | 2.48369105 |
| 14 | MP0008260_abnormal_autophagy | 2.30230639 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.19980595 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11446702 |
| 17 | MP0004858_abnormal_nervous_system | 2.10698437 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.04817129 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.01302172 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.99061176 |
| 21 | MP0003868_abnormal_feces_composition | 1.93974194 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.90284698 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 1.87399939 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.85698710 |
| 25 | MP0000609_abnormal_liver_physiology | 1.85495872 |
| 26 | MP0002249_abnormal_larynx_morphology | 1.77593206 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.71264955 |
| 28 | MP0003329_amyloid_beta_deposits | 1.69272096 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.60034725 |
| 30 | MP0000604_amyloidosis | 1.53226890 |
| 31 | MP0001873_stomach_inflammation | 1.52345183 |
| 32 | MP0001764_abnormal_homeostasis | 1.50307247 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49875524 |
| 34 | MP0005451_abnormal_body_composition | 1.48256854 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.43598454 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.43362107 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.41640745 |
| 38 | MP0003880_abnormal_central_pattern | 1.39234001 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.36564991 |
| 40 | MP0008569_lethality_at_weaning | 1.34787431 |
| 41 | MP0001664_abnormal_digestion | 1.34156634 |
| 42 | MP0000566_synostosis | 1.34058666 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.33931690 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.32510373 |
| 45 | MP0003866_abnormal_defecation | 1.31806639 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.28675919 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.21908458 |
| 48 | * MP0002735_abnormal_chemical_nociception | 1.18428960 |
| 49 | MP0005409_darkened_coat_color | 1.18214074 |
| 50 | MP0003123_paternal_imprinting | 1.16773606 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.16633444 |
| 52 | MP0009697_abnormal_copulation | 1.14349106 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.12521341 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.11140815 |
| 55 | MP0004147_increased_porphyrin_level | 1.06341257 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.04957696 |
| 57 | * MP0009745_abnormal_behavioral_response | 1.03633840 |
| 58 | MP0005375_adipose_tissue_phenotype | 1.01523225 |
| 59 | * MP0005535_abnormal_body_temperature | 0.96506389 |
| 60 | MP0002557_abnormal_social/conspecific_i | 0.94686564 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.94566917 |
| 62 | MP0003690_abnormal_glial_cell | 0.93273385 |
| 63 | MP0009764_decreased_sensitivity_to | 0.93150923 |
| 64 | MP0002234_abnormal_pharynx_morphology | 0.92103624 |
| 65 | MP0002064_seizures | 0.92048986 |
| 66 | MP0002063_abnormal_learning/memory/cond | 0.91658741 |
| 67 | MP0005647_abnormal_sex_gland | 0.91104133 |
| 68 | MP0008872_abnormal_physiological_respon | 0.90655942 |
| 69 | MP0000462_abnormal_digestive_system | 0.90486057 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.89965105 |
| 71 | * MP0001970_abnormal_pain_threshold | 0.89472510 |
| 72 | MP0004381_abnormal_hair_follicle | 0.88406411 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.88129765 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.88010438 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.85805716 |
| 76 | MP0004270_analgesia | 0.85657122 |
| 77 | MP0004043_abnormal_pH_regulation | 0.84784804 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.83720763 |
| 79 | MP0003011_delayed_dark_adaptation | 0.83610057 |
| 80 | MP0008874_decreased_physiological_sensi | 0.82491373 |
| 81 | MP0001905_abnormal_dopamine_level | 0.81881535 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.81661975 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.81317304 |
| 84 | * MP0002733_abnormal_thermal_nociception | 0.79324059 |
| 85 | MP0004947_skin_inflammation | 0.79100269 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.79094304 |
| 87 | MP0000598_abnormal_liver_morphology | 0.78359487 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.77444852 |
| 89 | MP0003634_abnormal_glial_cell | 0.76969410 |
| 90 | MP0002098_abnormal_vibrissa_morphology | 0.76609535 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.76499735 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.75464766 |
| 93 | MP0009763_increased_sensitivity_to | 0.75395408 |
| 94 | MP0008469_abnormal_protein_level | 0.74601521 |
| 95 | MP0003075_altered_response_to | 0.71760304 |
| 96 | MP0002272_abnormal_nervous_system | 0.71218210 |
| 97 | * MP0002066_abnormal_motor_capabilities/c | 0.71200330 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.71018380 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.69897624 |
| 100 | MP0003633_abnormal_nervous_system | 0.69686886 |
| 101 | MP0005448_abnormal_energy_balance | 0.69600251 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.69435344 |
| 103 | MP0002254_reproductive_system_inflammat | 0.69318614 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 0.69189145 |
| 105 | MP0003879_abnormal_hair_cell | 0.68416114 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.65078018 |
| 107 | MP0005334_abnormal_fat_pad | 0.64357008 |
| 108 | MP0001984_abnormal_olfaction | 0.62931030 |
| 109 | MP0002971_abnormal_brown_adipose | 0.61763691 |
| 110 | MP0001486_abnormal_startle_reflex | 0.61638018 |
| 111 | MP0001968_abnormal_touch/_nociception | 0.61474196 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.60597597 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.58955775 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.57583605 |
| 115 | MP0005166_decreased_susceptibility_to | 0.56526454 |
| 116 | MP0003186_abnormal_redox_activity | 0.56446083 |
| 117 | MP0003953_abnormal_hormone_level | 0.56361648 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.56262186 |
| 119 | MP0001661_extended_life_span | 0.56145358 |
| 120 | MP0002736_abnormal_nociception_after | 0.56140960 |
| 121 | MP0003631_nervous_system_phenotype | 0.54588674 |
| 122 | MP0002796_impaired_skin_barrier | 0.54314956 |
| 123 | MP0005408_hypopigmentation | 0.54250488 |
| 124 | MP0000920_abnormal_myelination | 0.53546611 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.52950809 |
| 126 | * MP0002069_abnormal_eating/drinking_beha | 0.52383351 |
| 127 | MP0006276_abnormal_autonomic_nervous | 0.51452983 |
| 128 | MP0005670_abnormal_white_adipose | 0.51385342 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.50827858 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.50790695 |
| 131 | MP0002928_abnormal_bile_duct | 0.50741072 |
| 132 | MP0004142_abnormal_muscle_tone | 0.49899457 |
| 133 | MP0004885_abnormal_endolymph | 0.49646364 |
| 134 | MP0001756_abnormal_urination | 0.47579188 |
| 135 | MP0006082_CNS_inflammation | 0.47563128 |
| 136 | MP0006035_abnormal_mitochondrial_morpho | 0.47559524 |
| 137 | MP0005551_abnormal_eye_electrophysiolog | 0.47444000 |
| 138 | MP0002229_neurodegeneration | 0.46045174 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.43331352 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.41891351 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.41126334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.89200832 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.49750557 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.27359092 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.00462860 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.97115165 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.69674393 |
| 7 | Xanthomatosis (HP:0000991) | 5.52877379 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.12055095 |
| 9 | Ankle clonus (HP:0011448) | 4.57602923 |
| 10 | Complement deficiency (HP:0004431) | 4.43840854 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.09733939 |
| 12 | Myokymia (HP:0002411) | 4.07147044 |
| 13 | Joint hemorrhage (HP:0005261) | 4.06861601 |
| 14 | Epidermoid cyst (HP:0200040) | 4.00297177 |
| 15 | Ketosis (HP:0001946) | 3.96259720 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 3.94366186 |
| 17 | Hyperammonemia (HP:0001987) | 3.92250872 |
| 18 | Fat malabsorption (HP:0002630) | 3.90247370 |
| 19 | Hyperglycinemia (HP:0002154) | 3.84592359 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83881658 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.83799206 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74796063 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.71257025 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.69435880 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68736154 |
| 26 | Stridor (HP:0010307) | 3.47332690 |
| 27 | Hyperglycinuria (HP:0003108) | 3.46958435 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.44290946 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.44290946 |
| 30 | Obstructive sleep apnea (HP:0002870) | 3.43052534 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.23982193 |
| 32 | J-shaped sella turcica (HP:0002680) | 3.17896217 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.16682504 |
| 34 | Spontaneous abortion (HP:0005268) | 3.15906677 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.15391509 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10160142 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 3.07897254 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.02939614 |
| 39 | Abnormality of complement system (HP:0005339) | 2.97866183 |
| 40 | Papilledema (HP:0001085) | 2.93648518 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93103860 |
| 42 | Ketoacidosis (HP:0001993) | 2.92624138 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.88518239 |
| 44 | Steatorrhea (HP:0002570) | 2.83784578 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.82993406 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77029367 |
| 47 | Acanthocytosis (HP:0001927) | 2.71970372 |
| 48 | Flat acetabular roof (HP:0003180) | 2.71090947 |
| 49 | Hyperventilation (HP:0002883) | 2.69392976 |
| 50 | Metabolic acidosis (HP:0001942) | 2.69152792 |
| 51 | Decreased circulating renin level (HP:0003351) | 2.63465116 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.62682381 |
| 53 | Growth hormone excess (HP:0000845) | 2.61880137 |
| 54 | Gout (HP:0001997) | 2.58481231 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.56327452 |
| 56 | Amelogenesis imperfecta (HP:0000705) | 2.55286863 |
| 57 | Vascular calcification (HP:0004934) | 2.55085836 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.52526869 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.45212909 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.44879199 |
| 61 | Cholecystitis (HP:0001082) | 2.44879199 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.44508364 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.42529815 |
| 64 | Skin nodule (HP:0200036) | 2.38568444 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.36864554 |
| 66 | Malnutrition (HP:0004395) | 2.36160993 |
| 67 | Akinesia (HP:0002304) | 2.35650307 |
| 68 | Spastic gait (HP:0002064) | 2.33100134 |
| 69 | Irritability (HP:0000737) | 2.31902253 |
| 70 | Status epilepticus (HP:0002133) | 2.29734944 |
| 71 | Supranuclear gaze palsy (HP:0000605) | 2.29111864 |
| 72 | Lethargy (HP:0001254) | 2.29074092 |
| 73 | Pili torti (HP:0003777) | 2.28398400 |
| 74 | Amyloidosis (HP:0011034) | 2.28219176 |
| 75 | Axonal loss (HP:0003447) | 2.26430826 |
| 76 | Mitral stenosis (HP:0001718) | 2.25684209 |
| 77 | Abnormal gallbladder morphology (HP:0012437) | 2.25042747 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.23909450 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23014677 |
| 80 | Widely patent fontanelles and sutures (HP:0004492) | 2.21869549 |
| 81 | Abnormality of the periventricular white matter (HP:0002518) | 2.21129003 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.20642450 |
| 83 | Brushfield spots (HP:0001088) | 2.20350590 |
| 84 | Cerebral palsy (HP:0100021) | 2.20154917 |
| 85 | Focal motor seizures (HP:0011153) | 2.19594419 |
| 86 | Alkalosis (HP:0001948) | 2.19555875 |
| 87 | Neonatal onset (HP:0003623) | 2.18251410 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.18071456 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 2.18071456 |
| 90 | Myocardial infarction (HP:0001658) | 2.17649823 |
| 91 | Confusion (HP:0001289) | 2.16799774 |
| 92 | Myopathic facies (HP:0002058) | 2.16681616 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16464183 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.16464183 |
| 95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16325093 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16325093 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16325093 |
| 98 | Bulbar palsy (HP:0001283) | 2.14355808 |
| 99 | Neurofibrillary tangles (HP:0002185) | 2.13839096 |
| 100 | Intention tremor (HP:0002080) | 2.13467722 |
| 101 | Ventricular fibrillation (HP:0001663) | 2.13267015 |
| 102 | Cardiovascular calcification (HP:0011915) | 2.13068481 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 2.12305714 |
| 104 | Cerebral edema (HP:0002181) | 2.08633891 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.07457246 |
| 106 | Hyperkalemia (HP:0002153) | 2.07344414 |
| 107 | Visual hallucinations (HP:0002367) | 2.06787134 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 2.06721040 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06721040 |
| 110 | Abdominal distention (HP:0003270) | 2.06667540 |
| 111 | Cholelithiasis (HP:0001081) | 2.06207012 |
| 112 | Rickets (HP:0002748) | 2.05840654 |
| 113 | Abnormality of renin-angiotensin system (HP:0000847) | 2.05299582 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 2.03522495 |
| 115 | Pancreatitis (HP:0001733) | 2.03490544 |
| 116 | Bundle branch block (HP:0011710) | 2.03275474 |
| 117 | Bronchomalacia (HP:0002780) | 2.02966034 |
| 118 | Glomerulonephritis (HP:0000099) | 2.02773415 |
| 119 | Neuronal loss in central nervous system (HP:0002529) | 2.02134930 |
| 120 | Diaphragmatic weakness (HP:0009113) | 2.02132221 |
| 121 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01421573 |
| 122 | Fair hair (HP:0002286) | 2.00799263 |
| 123 | Germ cell neoplasia (HP:0100728) | 2.00724579 |
| 124 | Hyperthyroidism (HP:0000836) | 2.00323841 |
| 125 | Acute hepatic failure (HP:0006554) | 1.98509155 |
| 126 | Vomiting (HP:0002013) | 1.98478101 |
| 127 | Late onset (HP:0003584) | 1.97225676 |
| 128 | Dysmetria (HP:0001310) | 1.97152115 |
| 129 | Clonus (HP:0002169) | 1.93840926 |
| 130 | Hypophosphatemia (HP:0002148) | 1.93392158 |
| 131 | Thin bony cortex (HP:0002753) | 1.93108094 |
| 132 | Gingival bleeding (HP:0000225) | 1.92277549 |
| 133 | Peripheral hypomyelination (HP:0007182) | 1.91730814 |
| 134 | Enlarged kidneys (HP:0000105) | 1.91357694 |
| 135 | Hyperparathyroidism (HP:0000843) | 1.91307796 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.91051020 |
| 137 | Broad face (HP:0000283) | 1.90199284 |
| 138 | Abnormality of the gallbladder (HP:0005264) | 1.88945106 |
| 139 | Menorrhagia (HP:0000132) | 1.88864600 |
| 140 | Sleep apnea (HP:0010535) | 1.87414372 |
| 141 | Opisthotonus (HP:0002179) | 1.86213754 |
| 142 | Poikilocytosis (HP:0004447) | 1.86123991 |
| 143 | Epileptic encephalopathy (HP:0200134) | 1.86014498 |
| 144 | Renal cortical cysts (HP:0000803) | 1.85021427 |
| 145 | Abnormality of vitamin metabolism (HP:0100508) | 1.84829264 |
| 146 | Right ventricular cardiomyopathy (HP:0011663) | 1.84315047 |
| 147 | Symptomatic seizures (HP:0011145) | 1.81839936 |
| 148 | Deformed sella turcica (HP:0002681) | 1.81762588 |
| 149 | Prolonged neonatal jaundice (HP:0006579) | 1.81229078 |
| 150 | Seborrheic dermatitis (HP:0001051) | 1.80402364 |
| 151 | Generalized aminoaciduria (HP:0002909) | 1.79384659 |
| 152 | Neoplasm of the heart (HP:0100544) | 1.77896920 |
| 153 | Double outlet right ventricle (HP:0001719) | 1.76526858 |
| 154 | Congenital malformation of the right heart (HP:0011723) | 1.76526858 |
| 155 | Syncope (HP:0001279) | 1.76355645 |
| 156 | Urinary urgency (HP:0000012) | 1.76042703 |
| 157 | Postural instability (HP:0002172) | 1.74968476 |
| 158 | Thrombophlebitis (HP:0004418) | 1.74760048 |
| 159 | Nuclear cataract (HP:0100018) | 1.74428033 |
| 160 | Heart block (HP:0012722) | 1.73978362 |
| 161 | Delayed myelination (HP:0012448) | 1.73366694 |
| 162 | Lower limb hyperreflexia (HP:0002395) | 1.73146330 |
| 163 | Abnormal hair laboratory examination (HP:0003328) | 1.72246308 |
| 164 | Urinary incontinence (HP:0000020) | 1.72152964 |
| 165 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72092662 |
| 166 | Spastic diplegia (HP:0001264) | 1.72042344 |
| 167 | Death in childhood (HP:0003819) | 1.71826158 |
| 168 | Exercise-induced myalgia (HP:0003738) | 1.71508100 |
| 169 | Colitis (HP:0002583) | 1.71454459 |
| 170 | Hemorrhage of the eye (HP:0011885) | 1.71276096 |
| 171 | Hyperaldosteronism (HP:0000859) | 1.70585846 |
| 172 | Visceral angiomatosis (HP:0100761) | 1.69822849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.87067905 |
| 2 | EPHA4 | 3.73900372 |
| 3 | FGFR4 | 3.67101246 |
| 4 | PRKD3 | 3.58966136 |
| 5 | BCKDK | 3.49097875 |
| 6 | NTRK3 | 2.74822829 |
| 7 | DAPK2 | 2.48783751 |
| 8 | MAP2K4 | 2.48549374 |
| 9 | MAP3K13 | 2.43189031 |
| 10 | INSRR | 2.27539697 |
| 11 | SMG1 | 2.25993854 |
| 12 | TAOK3 | 2.19420142 |
| 13 | SIK1 | 2.18709872 |
| 14 | TAOK1 | 2.12155097 |
| 15 | RIPK1 | 2.08045323 |
| 16 | TESK1 | 1.90351131 |
| 17 | EPHA2 | 1.81917384 |
| 18 | TNIK | 1.78407453 |
| 19 | PRKD2 | 1.75740533 |
| 20 | ERN1 | 1.73753711 |
| 21 | GRK6 | 1.70328509 |
| 22 | MAP2K7 | 1.69069414 |
| 23 | MAP3K4 | 1.68625184 |
| 24 | MAP3K7 | 1.67514204 |
| 25 | CAMK1D | 1.58902780 |
| 26 | MAP3K9 | 1.58177892 |
| 27 | MAP3K11 | 1.57159264 |
| 28 | EEF2K | 1.51400079 |
| 29 | CASK | 1.43691336 |
| 30 | TXK | 1.41851301 |
| 31 | PKN2 | 1.36863601 |
| 32 | JAK1 | 1.24238046 |
| 33 | TYK2 | 1.22326766 |
| 34 | MAPK15 | 1.21840865 |
| 35 | TESK2 | 1.21833934 |
| 36 | PRKCQ | 1.21652414 |
| 37 | MAPK11 | 1.16565174 |
| 38 | SIK2 | 1.14824753 |
| 39 | RIPK4 | 1.13234784 |
| 40 | SGK494 | 1.12357671 |
| 41 | SGK223 | 1.12357671 |
| 42 | KSR2 | 1.11316638 |
| 43 | ERBB4 | 1.10425618 |
| 44 | MAP3K14 | 1.09784126 |
| 45 | FGFR2 | 1.08783283 |
| 46 | PINK1 | 1.08513848 |
| 47 | MAP3K12 | 1.08056403 |
| 48 | UHMK1 | 1.06601680 |
| 49 | IRAK3 | 1.06020359 |
| 50 | PRKCG | 1.05683059 |
| 51 | IKBKE | 1.03725470 |
| 52 | MST1R | 1.02197619 |
| 53 | DAPK1 | 1.02096925 |
| 54 | FRK | 1.00175453 |
| 55 | OXSR1 | 0.98821287 |
| 56 | ITK | 0.97615291 |
| 57 | JAK2 | 0.97298201 |
| 58 | SGK2 | 0.96684906 |
| 59 | NME1 | 0.95696025 |
| 60 | CAMK2B | 0.95113721 |
| 61 | CAMK2G | 0.95032503 |
| 62 | ICK | 0.94591691 |
| 63 | STK38 | 0.94445140 |
| 64 | NTRK2 | 0.94078514 |
| 65 | ARAF | 0.93955771 |
| 66 | MAP3K2 | 0.93323194 |
| 67 | RPS6KA2 | 0.92926873 |
| 68 | MAP4K1 | 0.92019443 |
| 69 | BMPR2 | 0.92019085 |
| 70 | FER | 0.91700300 |
| 71 | SGK3 | 0.90857310 |
| 72 | AKT3 | 0.90467726 |
| 73 | MINK1 | 0.90376463 |
| 74 | LMTK2 | 0.89745270 |
| 75 | SCYL2 | 0.89593515 |
| 76 | NEK6 | 0.88468707 |
| 77 | CAMK1G | 0.86968361 |
| 78 | PRKCH | 0.86712438 |
| 79 | FES | 0.85871638 |
| 80 | PRKCI | 0.85063765 |
| 81 | PRKCZ | 0.84932556 |
| 82 | MAP2K2 | 0.84924922 |
| 83 | CAMK2A | 0.84751572 |
| 84 | MAP2K6 | 0.84098841 |
| 85 | MAPKAPK3 | 0.83742069 |
| 86 | PDK1 | 0.82947156 |
| 87 | MAP3K1 | 0.82519116 |
| 88 | DYRK1B | 0.81506533 |
| 89 | EPHA3 | 0.80078806 |
| 90 | CAMK1 | 0.78811619 |
| 91 | NTRK1 | 0.78552153 |
| 92 | MAPK12 | 0.78447876 |
| 93 | PTK6 | 0.78329428 |
| 94 | TNK2 | 0.76523688 |
| 95 | PRKG2 | 0.75658787 |
| 96 | MARK2 | 0.73891689 |
| 97 | PHKG1 | 0.73854611 |
| 98 | PHKG2 | 0.73854611 |
| 99 | PDPK1 | 0.73716980 |
| 100 | PAK6 | 0.72355945 |
| 101 | CDK5 | 0.71097894 |
| 102 | MAPK7 | 0.70467299 |
| 103 | PAK3 | 0.69850042 |
| 104 | WNK4 | 0.69756675 |
| 105 | STK39 | 0.68857210 |
| 106 | PKN1 | 0.66433181 |
| 107 | CAMKK1 | 0.66174962 |
| 108 | IRAK2 | 0.65781629 |
| 109 | MAP3K6 | 0.64870485 |
| 110 | EPHB1 | 0.64837382 |
| 111 | FLT3 | 0.63768730 |
| 112 | PIM2 | 0.63055038 |
| 113 | KSR1 | 0.62616814 |
| 114 | PTK2B | 0.62578291 |
| 115 | PRKAA1 | 0.60957920 |
| 116 | PIK3CG | 0.59805325 |
| 117 | RPS6KL1 | 0.59006778 |
| 118 | RPS6KC1 | 0.59006778 |
| 119 | FGFR3 | 0.59003819 |
| 120 | SIK3 | 0.58975872 |
| 121 | TYRO3 | 0.58617177 |
| 122 | GRK5 | 0.57513829 |
| 123 | KIT | 0.54707283 |
| 124 | PRPF4B | 0.52835408 |
| 125 | MARK1 | 0.52833034 |
| 126 | ZAP70 | 0.52426803 |
| 127 | PRKACG | 0.52259671 |
| 128 | SYK | 0.52085459 |
| 129 | PRKD1 | 0.52060216 |
| 130 | CSK | 0.51565556 |
| 131 | RAF1 | 0.50787432 |
| 132 | STK11 | 0.50395406 |
| 133 | SGK1 | 0.49283782 |
| 134 | JAK3 | 0.48967556 |
| 135 | PRKCA | 0.48940433 |
| 136 | MAPKAPK5 | 0.48298315 |
| 137 | TBK1 | 0.48046105 |
| 138 | MAPK13 | 0.46586919 |
| 139 | PRKAA2 | 0.46511914 |
| 140 | ERBB2 | 0.45850824 |
| 141 | HIPK2 | 0.45781517 |
| 142 | PTK2 | 0.45580992 |
| 143 | CSNK1G2 | 0.45383876 |
| 144 | RET | 0.45139638 |
| 145 | RPS6KA6 | 0.44556387 |
| 146 | CSF1R | 0.44082460 |
| 147 | MAPK4 | 0.43951592 |
| 148 | TAOK2 | 0.41823299 |
| 149 | CAMK4 | 0.38350465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44003662 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46411926 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24744565 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19172529 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97600913 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60948417 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57239895 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35542503 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26388122 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18463908 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17871650 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17649051 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13532548 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12348113 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11192504 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05985659 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.97940882 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88320097 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82858038 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81693979 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.71869360 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66165549 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63754293 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62481152 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62150396 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61187423 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59729696 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56173189 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56009893 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53626150 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53203168 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50246131 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47599998 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47467833 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44729774 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43218807 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39050005 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.37596653 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35598940 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.32227740 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28242205 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26899899 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26833527 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26453636 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24908407 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23993162 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20203138 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14842299 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13025194 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08135167 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05832054 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99371149 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98673504 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96494053 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94671329 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94043478 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91650514 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85051454 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84394643 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84132623 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81147832 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76969446 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76538836 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73412720 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71388687 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68716798 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68190622 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67816580 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67594584 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66599137 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66339559 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66102002 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65794464 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.64572798 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63836560 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63305793 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61328898 |
| 78 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59640340 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57935738 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56883558 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56713133 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54553243 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54070221 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52487307 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47184942 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47170639 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45726392 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44822850 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40463785 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.39839118 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39706005 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37800065 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37046590 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32415244 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30757460 |
| 96 | Insulin secretion_Homo sapiens_hsa04911 | 0.29650765 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28566217 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27974725 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24834629 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24457612 |
| 101 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24045611 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23262968 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21041097 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20769252 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20424421 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19978421 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.19369912 |
| 108 | Salivary secretion_Homo sapiens_hsa04970 | 0.16413406 |
| 109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15933518 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15203656 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.13325462 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12813167 |
| 113 | Morphine addiction_Homo sapiens_hsa05032 | 0.12094821 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11924790 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.11773371 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.10237375 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09506255 |
| 118 | Taste transduction_Homo sapiens_hsa04742 | 0.09283157 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08710449 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07210646 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.06579980 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.04701030 |
| 123 | Renin secretion_Homo sapiens_hsa04924 | 0.04496300 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.02952299 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.01279834 |

